Search

everythinglearnresearchcommunity

for

Search:↓

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Both genetic and lifestyle factors significantly affect female hair loss.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Men can experience female pattern hair loss, needing different treatments.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Managing emotional distress, obesity, insulin resistance, and high male hormones is crucial for improving well-being in women with PCOS.

Anabolic-androgenic steroids are dangerous and educating people about their risks is essential.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Removing both ovaries treated the woman's excess male hormone symptoms.

Individualized treatment improves symptoms and quality of life for women with PCOS.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Quercetin may help with PCOS symptoms, but more research is needed.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Androgens can both increase and decrease hair growth in different parts of the body.

Sebocytes play a key role in controlling androgen levels in human skin.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Too much androgen can cause hair loss; finasteride may help.